ELV Quote, Financials, Valuation and Earnings

Centene Corp. has a net margin of 1.1% compared to Elevance Health, Inc.'s net margin of -2.21%. Elevance Health, Inc.'s return on equity of 13.1% beat Centene Corp.'s return on equity of -27.11%.

Elevance Health, Inc. has a consensus price target of $387.85, signalling upside risk potential of 11.39%. On the other hand Centene Corp. has an analysts' consensus of $44.24 which suggests that it could grow by 1.27%. Given that Elevance Health, Inc. has higher upside potential than Centene Corp., analysts believe Elevance Health, Inc. is more attractive than Centene Corp..

Elevance Health, Inc. has a beta of 0.500, which suggesting that the stock is 50.02% less volatile than S&P 500. In comparison Centene Corp. has a beta of 0.483, suggesting its less volatile than the S&P 500 by 51.703%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 1.97%. Centene Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health, Inc. pays 27.13% of its earnings as a dividend. Centene Corp. pays out -- of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $49.7B, which are larger than Centene Corp. quarterly revenues of $49.7B. Elevance Health, Inc.'s net income of $546M is higher than Centene Corp.'s net income of -$1.1B. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.87x while Centene Corp.'s PE ratio is 8.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.11x for Centene Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare, Inc. has a net margin of 1.1% compared to Elevance Health, Inc.'s net margin of -1.41%. Elevance Health, Inc.'s return on equity of 13.1% beat Molina Healthcare, Inc.'s return on equity of 10.89%.

Elevance Health, Inc. has a consensus price target of $387.85, signalling upside risk potential of 11.39%. On the other hand Molina Healthcare, Inc. has an analysts' consensus of $161.75 which suggests that it could grow by 9.11%. Given that Elevance Health, Inc. has higher upside potential than Molina Healthcare, Inc., analysts believe Elevance Health, Inc. is more attractive than Molina Healthcare, Inc..

Elevance Health, Inc. has a beta of 0.500, which suggesting that the stock is 50.02% less volatile than S&P 500. In comparison Molina Healthcare, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.546%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 1.97%. Molina Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health, Inc. pays 27.13% of its earnings as a dividend. Molina Healthcare, Inc. pays out -- of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $49.7B, which are larger than Molina Healthcare, Inc. quarterly revenues of $11.4B. Elevance Health, Inc.'s net income of $546M is higher than Molina Healthcare, Inc.'s net income of -$160M. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.87x while Molina Healthcare, Inc.'s PE ratio is 17.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.17x for Molina Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health, Inc. has a net margin of 1.1% compared to Elevance Health, Inc.'s net margin of -12.56%. Elevance Health, Inc.'s return on equity of 13.1% beat Oscar Health, Inc.'s return on equity of -40.11%.

Elevance Health, Inc. has a consensus price target of $387.85, signalling upside risk potential of 11.39%. On the other hand Oscar Health, Inc. has an analysts' consensus of $15.40 which suggests that it could grow by 12.16%. Given that Oscar Health, Inc. has higher upside potential than Elevance Health, Inc., analysts believe Oscar Health, Inc. is more attractive than Elevance Health, Inc..

Elevance Health, Inc. has a beta of 0.500, which suggesting that the stock is 50.02% less volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 1.97%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health, Inc. pays 27.13% of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $49.7B, which are larger than Oscar Health, Inc. quarterly revenues of $2.8B. Elevance Health, Inc.'s net income of $546M is higher than Oscar Health, Inc.'s net income of -$352.4M. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.87x while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.32x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group, Inc. has a net margin of 1.1% compared to Elevance Health, Inc.'s net margin of 0.19%. Elevance Health, Inc.'s return on equity of 13.1% beat UnitedHealth Group, Inc.'s return on equity of 17.57%.

Elevance Health, Inc. has a consensus price target of $387.85, signalling upside risk potential of 11.39%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $364.63 which suggests that it could grow by 25.76%. Given that UnitedHealth Group, Inc. has higher upside potential than Elevance Health, Inc., analysts believe UnitedHealth Group, Inc. is more attractive than Elevance Health, Inc..

Elevance Health, Inc. has a beta of 0.500, which suggesting that the stock is 50.02% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.409, suggesting its less volatile than the S&P 500 by 59.094%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 1.97%. UnitedHealth Group, Inc. offers a yield of 3.01% to investors and pays a quarterly dividend of $2.21 per share. Elevance Health, Inc. pays 27.13% of its earnings as a dividend. UnitedHealth Group, Inc. pays out 65.97% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $49.7B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Elevance Health, Inc.'s net income of $546M is higher than UnitedHealth Group, Inc.'s net income of $218M. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.87x while UnitedHealth Group, Inc.'s PE ratio is 21.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.59x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.